Market & Commercial Readiness Workshop
Market & Commercial Readiness Workshop
Objective
Objective
Workshop Online, two half-days per product(line), focused on turning your pipeline and plans into clear, evidence-based growth paths.
Workshop Online, two half-days per product(line), focused on turning your pipeline and plans into clear, evidence-based growth paths.
Day 1 - Diagnostic Deep Dive
Understanding of: Product & pipeline mapping Current portfolio and pipeline per indication, lifecycle stage, key differentiators.
Clinical status Available evidence, key studies, ongoing trials, data gaps, implications for claims and value messaging.
Regulatory status Approvals, submissions, MDR/FDA position, key constraints and opportunities in communication.
Value proposition, features & benefits Clinical, economic and operational value drivers; alignment with customer needs and competitive context.
Commercialisation status Pricing, reimbursement, launch status, key markets, channels, reference sites, KOL engagement.
Marketing & go-to-market structure Current campaigns, tools, sales enablement, digital presence, events, distributor support.
International footprint & ambition Existing countries, partners, barriers, white spots, and priority markets.
Growth expectations Volume, revenue, timeline, and internal success criteria.
Day 1 - Diagnostic Deep Dive
Understanding of: Product & pipeline mapping Current portfolio and pipeline per indication, lifecycle stage, key differentiators.
Clinical status Available evidence, key studies, ongoing trials, data gaps, implications for claims and value messaging.
Regulatory status Approvals, submissions, MDR/FDA position, key constraints and opportunities in communication.
Value proposition, features & benefits Clinical, economic and operational value drivers; alignment with customer needs and competitive context.
Commercialisation status Pricing, reimbursement, launch status, key markets, channels, reference sites, KOL engagement.
Marketing & go-to-market structure Current campaigns, tools, sales enablement, digital presence, events, distributor support.
International footprint & ambition Existing countries, partners, barriers, white spots, and priority markets.
Growth expectations Volume, revenue, timeline, and internal success criteria.
Day 2 - Pathways & Priorities
Potential pathways for market growth
Growth pathways by product(line) Priority segments, clinical settings, and use cases where you can win.
International expansion opportunities Target geographies, entry strategies, distributor/partner model implications.
Positioning & messaging refinement Clear, evidence-backed storylines per stakeholder (clinician, nurse, admin, procurement, payer).
Marketing optimisation Gaps and quick wins in your current activities: digital presence, campaigns, tools, KOL strategy, congress and field activation.
Short-term action plan (0–6 months) 5–10 pragmatic, ranked actions per product(line), including owners and expected impact.
Mid-term roadmap (6–24 months) Scalable initiatives to support sustainable growth and future launches.
Day 2 - Pathways & Priorities
Potential pathways for market growth
Growth pathways by product(line) Priority segments, clinical settings, and use cases where you can win.
International expansion opportunities Target geographies, entry strategies, distributor/partner model implications.
Positioning & messaging refinement Clear, evidence-backed storylines per stakeholder (clinician, nurse, admin, procurement, payer).
Marketing optimisation Gaps and quick wins in your current activities: digital presence, campaigns, tools, KOL strategy, congress and field activation.
Short-term action plan (0–6 months) 5–10 pragmatic, ranked actions per product(line), including owners and expected impact.
Mid-term roadmap (6–24 months) Scalable initiatives to support sustainable growth and future launches.
FAQ
Frequently asked questions
Who is this for?
Medtech ventures and investors who need a structured, partner-oriented commercial engine rather than ad-hoc outreach or isolated pilots.
What outcomes can we expect?
How do you work with our existing BD or sales team?
What do you need from us to start?
How quickly do we see movement?
Who is this for?
Medtech ventures and investors who need a structured, partner-oriented commercial engine rather than ad-hoc outreach or isolated pilots.